SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-15-000364
Filing Date
2015-03-16
Accepted
2015-03-16 15:00:40
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kbio-20141231x10k.htm 10-K 2661593
2 EX-23.1 kbio-20141231ex23148adfc.htm EX-23.1 2731
3 EX-31.1 kbio-20141231ex311ca12f3.htm EX-31.1 18127
4 EX-31.2 kbio-20141231ex3123038e6.htm EX-31.2 17648
5 EX-32.1 kbio-20141231ex3210bed6e.htm EX-32.1 8012
6 EX-32.2 kbio-20141231ex322fb46d3.htm EX-32.2 7774
7 GRAPHIC kbio-20141231x10kg001.jpg GRAPHIC 21835
  Complete submission text file 0001558370-15-000364.txt   12437259

Data Files

Seq Description Document Type Size
8 EX-101.INS kbio-20141231.xml EX-101.INS 1944967
9 EX-101.SCH kbio-20141231.xsd EX-101.SCH 56394
10 EX-101.CAL kbio-20141231_cal.xml EX-101.CAL 43292
11 EX-101.DEF kbio-20141231_def.xml EX-101.DEF 189454
12 EX-101.LAB kbio-20141231_lab.xml EX-101.LAB 550510
13 EX-101.PRE kbio-20141231_pre.xml EX-101.PRE 390497
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35798 | Film No.: 15702419
SIC: 2834 Pharmaceutical Preparations